| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |